Related Experiment Video
Updated: Aug 5, 2026

05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Restrictive vs Liberal Transfusion Strategy After Myocardial Infarction: A Post Hoc Analysis of the MINT Randomized
Marnie Bertolet1, Francois Martin Carrier2,3,4, Simone Glynn5
1Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
JAMA Network Open
|July 27, 2026
Summary
A liberal transfusion strategy for patients with myocardial infarction (MI) and anemia may reduce the risk of 30-day death or MI. This approach may outweigh the increased risk of heart failure, suggesting it could be reasonable.
Area of Science:
- Cardiology
- Hematology
- Clinical Trials
Background:
- Anemia in patients with myocardial infarction (MI) presents a complex clinical challenge.
- Deciding on transfusion thresholds involves balancing the risk of further ischemic events against potential adverse effects like heart failure.
Purpose of the Study:
- To compare liberal versus restrictive hemoglobin transfusion strategies in patients hospitalized with MI and anemia.
- To estimate the risk differences and probabilities associated with each strategy for 30-day death or MI and heart failure.
Main Methods:
- The Myocardial Ischemia and Transfusion (MINT) trial randomized 3504 adults with MI and anemia.
- Participants were assigned to either a restrictive (hemoglobin <7-8 g/dL) or liberal (hemoglobin >10 g/dL) transfusion strategy.
- Bayesian analysis estimated posterior risk differences and probabilities for key outcomes.
Main Results:
- The liberal strategy was associated with a 1.4%-2.4% lower risk of 30-day death or MI, with probabilities ranging from 89.1% to 98.8% for benefit.
- Conversely, the liberal strategy showed a 0.2%-0.6% higher risk of heart failure, with probabilities of harm ranging from 60.6% to 80.0%.
Conclusions:
- A liberal transfusion strategy in MI patients with anemia may reduce 30-day death or MI risk, potentially outweighing the increased heart failure risk.
- This strategy may be reasonable, aligning with guidelines and patient-specific risk assessments.